08.13.25 -- CDISC's New 360i Helps Move Trial Design From Manual To Modern

Learn how to develop and utilize a successful DCT framework, enabling your study to enhance patient access, improve data quality, and streamline study operations.

Integrating biomarkers into early clinical studies is crucial to determine whether a new therapy engages its biological target, triggers the intended PD effects, and shows early signs of efficacy.

Explore the implications of a connection between semaglutide and an increased risk of non-arteritic anterior ischemic optic neuropathy (NAION).

Explore the key advantages of stick-pack formats for pharmaceuticals and nutraceuticals, from enhanced product safety and cost-efficiency to improved compliance and marketability.

How can effective hazard communication and SOPs from institutional biosafety committees enhance safety in clinical trials involving rDNA technologies and genetically modified biological agents?

This episode of Suvoda's ClinTech Podcast, delves into the strategic merger of Suvoda and Greenphire, highlighting how their combined capabilities are poised to transform clinical trial operations.

Ensuring drugs reach patients at the right time and place is crucial. Review key areas to consider as you build a robust clinical supply chain that supports global trials effectively and efficiently.

This time-sensitive Phase 3 trial in dry eye disease required precision project management leveraging strong site relationships, ophthalmology-specific expertise, and data-driven site selection.